-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWo8/iVX6Ied7qFwi5eAKyFHWfOYePsRHJ0Gl+u6vuqnX22+wqGMTg2kiIsNIynP x3hJ/cS+YWt0+HTLnDhE1Q== 0001358877-10-000003.txt : 20101220 0001358877-10-000003.hdr.sgml : 20101220 20101220142443 ACCESSION NUMBER: 0001358877-10-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 EFFECTIVENESS DATE: 20101220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIMERICK BIOPHARMA INC CENTRAL INDEX KEY: 0001358877 IRS NUMBER: 061735053 STATE OF INCORPORATION: CA FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-152195 FILM NUMBER: 101262526 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD STREET 2: #700 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-742-0110 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD STREET 2: #700 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: LIMERICK NEUROSCIENES INC DATE OF NAME CHANGE: 20060410 D 1 primary_doc.xml X0704 D LIVE 0001358877 LIMERICK BIOPHARMA INC 601 GATEWAY BOULEVARD Suite 1050 SO. SAN FRANCISCO CA CALIFORNIA 94080 650-742-0110 CALIFORNIA Efflux Technology, Inc. LIMERICK NEUROSCIENES INC Corporation true Wendye Robbins c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Ving Lee c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Executive Officer Asha Rajagopal c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Executive Officer Kristina Burow c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Director Steve Dow c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Director Corey Goodman c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Director Chad Waite c/o Limerick BioPharma, Inc. 601 Gateway Blvd., Suite 1050 South San Francisco CA CALIFORNIA 94080 Director Pharmaceuticals Decline to Disclose 06 false 2010-11-03 false true true true true Convertible Promissory Notes and Warrants incl. the shares of Preferred Stock issuable upon conv. of the Notes, the shares of Preferred Stock issuable upon exercise of the Warrants, and the shares of Common Stock issuable upon conv. of the Preferred Stock false 0 3585000 3585000 0 false 13 0 0 0 false LIMERICK BIOPHARMA INC \s\ Alan C. Mendelson Alan C. Mendelson Secretary 2010-12-18 -----END PRIVACY-ENHANCED MESSAGE-----